Lobbying client
SUCAMPO PHARMACEUTICALS INC.
Pharmaceutical
The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 4 of its records are shown together here.
Filings
35
Filed by
4
Reported in-house
—
Reported by firms
$700,000
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2011 to 2018
Filings
35 filings, newest first.
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) | 14 | $260,000 |
| FIERCE, ISAKOWITZ & BLALOCK | 4 | $210,000 |
| WILMER CUTLER PICKERING HALE AND DORR LLP | 8 | $190,000 |
| COVINGTON & BURLING LLP | 4 | $40,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 15 |
| Pharmacy | PHA | 10 |
| Trade (domestic/foreign) | TRD | 4 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.